Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€162.42
21.03.22
€180.00
21.03.23
-2.20%
04.04.22

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Lipocine Inc.

Start price
Target price
Perf. (%)
€25.25
21.03.22
€0.000
21.03.23
-19.90%
02.04.22

Below average Management
high free float
High risks for its business
Unknown brand
buy
Nagarro SE

Start price
Target price
Perf. (%)
€148.00
21.03.22
-
21.03.23
-41.28%
29.09.22

buy
Enservco Corp.

Start price
Target price
Perf. (%)
€2.84
21.03.22
€5.40
21.03.23
-14.79%
04.04.22

Could be very worthwhile Investment >20% year
buy
Kinross Gold Corp.

Start price
Target price
Perf. (%)
€5.14
21.03.22
-
21.03.23
6.19%
02.04.22

Could be worthwhile Investment >10% per year
buy
Naked Brand Group Ltd.

Start price
Target price
Perf. (%)
€1.78
20.03.22
-
20.03.23
-77.97%
21.03.23

Could be very worthwhile Investment >20% year
PAVmed Inc

Start price
Target price
Perf. (%)
€1.41
20.03.22
-
20.03.23
-80.13%
21.03.23

Probably not worthwhile Investment
Bovie Medical Corp

Start price
Target price
Perf. (%)
€6.45
20.03.22
-
20.03.23
-8.53%
28.05.22

Risky Investment
buy
Takkt AG

Start price
Target price
Perf. (%)
€15.44
19.03.22
€17.00
19.03.23
1.81%
04.04.22

Standard Investments for future growth
Differentiated customer and product portfolio
Top 10 in its market
Higher risks for its business
buy
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.10
19.03.22
€9.00
19.03.23
-31.87%
20.03.23

Could be worthwhile Investment >10% per year
buy
Shopify Inc

Start price
Target price
Perf. (%)
€62.00
19.03.22
-
19.03.23
1.16%
01.04.22

Risky Investment
buy
StoneCo Ltd

Start price
Target price
Perf. (%)
€12.50
19.03.22
-
19.03.23
-12.09%
01.04.22

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Higher risks for its business
buy
Tencent Music Entertainment Gr

Start price
Target price
Perf. (%)
€4.64
19.03.22
-
19.03.23
-2.37%
01.04.22

Risky Investment
buy
Baidu Inc.

Start price
Target price
Perf. (%)
€16.20
19.03.22
-
19.03.23
-1.93%
01.04.22

Very Future proof/growth oriented business model
buy
Alibaba Group Holding Ltd ADR

Start price
Target price
Perf. (%)
€92.20
19.03.22
-
19.03.23
8.19%
01.04.22

Leading role in innovation
Market Leader or Top 3
Very Future proof/growth oriented business model
Higher risks for its business
buy
JinkoSolar Holding Co. Ltd. ADR

Start price
Target price
Perf. (%)
€46.62
19.03.22
-
17.05.24
-49.49%
07.05.24

EBIT growth >5% per year expected
Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Normal challenges to pay loans and raise capital
buy
Gaotu Techedu Inc. ADR

Start price
Target price
Perf. (%)
€1.95
19.03.22
€5.00
19.03.23
88.69%
20.03.23

Could be worthwhile Investment >10% per year
buy
Prosus N.V.

Start price
Target price
Perf. (%)
€52.80
19.03.22
€65.00
19.03.23
20.11%
20.03.23

Could be worthwhile Investment >10% per year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€160.00
18.03.22
€200.00
18.03.23
-12.75%
19.03.23

Could be worthwhile Investment >10% per year
Mullen Automotive Inc.

Start price
Target price
Perf. (%)
€2.62
18.03.22
-
18.03.23
0.02%
02.04.22

Risky Investment
buy
Roku

Start price
Target price
Perf. (%)
€110.50
18.03.22
€130.00
18.03.23
-20.36%
26.04.22

Sonim Technologies Inc

Start price
Target price
Perf. (%)
€1.33
18.03.22
-
18.03.23
-9.77%
18.03.22

Risky Investment
buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€212.90
18.03.22
€240.00
18.03.23
-0.42%
21.03.22

Could be worthwhile Investment >10% per year
buy
Tesla Inc

Start price
Target price
Perf. (%)
€262.03
18.03.22
-
18.03.23
15.90%
25.03.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
buy
Encavis AG

Start price
Target price
Perf. (%)
€17.97
18.03.22
-
18.03.23
9.07%
01.04.22